ClinicalTrials.gov: NIH Busy Educating Sponsors On Mandates While Regs Remain In The Works
This article was originally published in The Pink Sheet Daily
Draft rules are still being developed to fully implement ClinicalTrials.gov, but the law has been in effect for some time and officials say they are making a consistent effort to ensure study sponsors are educated on their new responsibilities.
You may also be interested in...
The National Institutes of Health is still drafting regulations, but Rep. Markey’s TEST Act, which would impose more extensive reporting requirements, has won praise from stakeholders for some of its definitional details. In an election season, its prospects for passing are slim, but aspects of the legislation could serve as a model for pending regulations.
After about a week of debate, the Senate overwhelmingly passes its FDA user fee package, with only track and trace to be finalized. House members are scheduled to begin floor debate after Memorial Day in the hopes of sending the bill to President Obama before July 4.
Device and drug firms must begin posting serious and frequent adverse event data from certain clinical trials on the National Institutes of Health's ClinicalTrials.gov database by September, NIH confirmed April 20